A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

By A. Sanyal, T. Boyer, G. Garcia‐Tsao, F. Regenstein, L. Rossaro, B. Appenrodt, A. Blei, V. Gülberg, S. Sigal, Peter Teuber. Gastroenterology, 2008

624 citations recorded by the source corpus.